Acute lymphoblastic leukemia Leucemia linfoblástica aguda

Contenido principal del artículo

Francisco Fabian Granados Romero
https://orcid.org/0000-0003-1242-5391
Enma maría Guadamud Lorenti
https://orcid.org/0000-0002-8851-0130

Resumen




Acute lymphoblastic leukemia is the most common hematologic neoplasm in pediatric age. Acute lymphoblastic leukemia (ALL) comprises 80% of all acute leukemias in this age group. Although the etiology is unknown, some genetic, viral and environmental predisposing factors have been detailed. The clinical manifestations are usually the result of bone marrow by leukemic cells (anemia, thrombopenia and neutropenia). The diagnosis is made by morphological, cytogenetic and molecular analysis of bone marrow aspirate. The treatment lasts about two years. The prognosis of children with acute lymphoblastic leukemia has improved brilliantly in recent decades thanks to new drugs and treatment tailored to patients' risk.




Detalles del artículo

Cómo citar
Granados Romero, F. F., & Guadamud Lorenti, E. maría. (2018). Acute lymphoblastic leukemia: Leucemia linfoblástica aguda. Journal of American Health, 1(1), 1–5. https://doi.org/10.37958/jah.v1i1.1
Sección
Articles

Artículos más leídos del mismo autor/a